Moxifloxacin Eye Drop

Material: Moxiflacin 0.5% eye drops: per ml There are 5 mg of moxifloxacin Equvalent to the moxifloxacin hydrochloride INN

Instructions: 0.5% of eyesight in moxifloxacin is indicated by congenital inflammation caused by the following germs: Aroobic Village-Positive Germs: Cinebacterium Species, Micrococcus luteus, Staphylococcus aureus, Staphylococcus eipardimidis, Staphylococcus hemolyticus, Staphylococcus hominis, Staphylococcus warrior, Streptococcus pneumonee, St. Raptococcus videadens group Aroobic Village-Negative Bacteria: Acetateobacter lupine, Hypophilus influenza, Hypophilus paras Influenza Other bacteria: Chlamydia trachamatis

Dimensions and Usage Rules: Apply one drops in the infected eyes 3 times a day. Duration of treatment: 7 days.

In cases where it can not be used: These medicines can not be used for sensitive patients against moxifloxacin, other quinolones and other substances of this drug.


Use during pregnancy and breastfeeding: Since this drug is not available in pregnancy, it is necessary to apply the medicines considering the risk of fetal and the benefit of the patient. It has not been tested whether humans are immunized in the milk of moxifloxacin.
Side effects: Commonly seen side effects include conjunctive inflammation, reducing visceral vision, eye dryness, corneal inflammation, perspiration in the eyes, hypermia, pain, itching, subcutaneous bleeding and watering through the eyes. These side effects are seen in patients from 1 to 6% of patients. Other side effects are fever, cough increase, mediate inflammation, infection of the germs caused by infection, inflammation of the fumes, rashes and rhinitis. These side effects can be found in 1-4% of patients.

āωāĻĒাāĻĻাāύ : āĻŽāĻ•্āϏিāĻĢ্āϞāĻ•্āϏাāϏিāύ ā§Ļ.ā§Ģ% āϚোāĻ–েāϰ āĻĄ্āϰāĻĒāϏ্‌: āĻĒ্āϰāϤি āĻŽি.āϞি. āĻ āφāĻ›ে āĻŽāĻ•্āϏিāĻĢ্āϞāĻ•্āϏাāϏিāύ ā§Ģ āĻŽি.āĻ—্āϰা. āĻāϰ āϏāĻŽāϤুāϞ্āϝ āĻŽāĻ•্āϏিāĻĢ্āϞāĻ•্āϏাāϏিāύ āĻšাāχāĻĄ্āϰোāĻ•্āϞোāϰাāχāĻĄ āφāχāĻāύāĻāύ।

āύিāϰ্āĻĻেāĻļāύা : āĻŽāĻ•্āϏিāĻĢ্āϞāĻ•্āϏাāϏিāύ ā§Ļ.ā§Ģ% āϚোāĻ–েāϰ āĻĄ্āϰāĻĒāϏ্‌ āύিāĻŽ্āύāϞিāĻ–িāϤ āϜীāĻŦাāĻŖু āĻĻ্āĻŦাāϰা āϏৃāώ্āϟ āĻ•āύāϜাংāϟিāĻ­াāϰ āĻĒ্āϰāĻĻাāĻšে āύিāϰ্āĻĻেāĻļিāϤ: āĻāϰোāĻŦিāĻ• āĻ—্āϰাāĻŽ-āĻĒāϜিāϟিāĻ­ āϜীāĻŦাāĻŖু: āĻ•āϰিāύেāĻŦ্āϝাāĻ•āϟেāϰিāϝ়াāĻŽ āϏ্āĻĒিāϏিāϜ, āĻŽাāχāĻ•্āϰোāĻ•āĻ•্āĻ•াāϏ āϞুāϟিāϝ়াāϏ, āϏ্āϟ্āϝাāĻĢাāχāϞোāĻ•āĻ•্āĻ•াāϏ āĻ…āϰিāϝ়াāϏ, āϏ্āϟ্āϝাāĻĢাāχāϞোāĻ•āĻ•্āĻ•াāϏ āχāĻĒিāĻĄাāϰāĻŽিāĻĄিāϏ, āϏ্āϟ্āϝাāĻĢাāχāϞোāĻ•āĻ•্āĻ•াāϏ āĻšেāĻŽোāϞাāχāϟিāĻ•াāϏ, āϏ্āϟ্āϝাāĻĢাāχāϞোāĻ•āĻ•্āĻ•াāϏ āĻšোāĻŽিāύিāϏ, āϏ্āϟ্āϝাāĻĢাāχāϞোāĻ•āĻ•্āĻ•াāϏ āĻ“āϝ়াāϰāύাāϰি, āϏ্āϟ্āϰেāĻĒāϟোāĻ•āĻ•্āĻ•াāϏ āύিāωāĻŽোāύি, āϏ্āϟ্āϰেāĻĒāϟোāĻ•āĻ•্āĻ•াāϏ āĻ­িāϰিāĻĄ্āϝাāύ্āϏ āĻ—্āϰুāĻĒ āĻāϰোāĻŦিāĻ• āĻ—্āϰাāĻŽ-āύেāĻ—েāϟিāĻ­ āϜীāĻŦাāĻŖু: āĻ্āϝাāϏিāύেāϟোāĻŦ্āϝাāĻ•āϟাāϰ āϞোāĻĢি, āĻšিāĻŽোāĻĢিāϞাāϏ āχāύāĻĢ্āϞুāϝ়েāĻž্āϜা, āĻšিāĻŽোāĻĢিāϞাāϏ āĻĒ্āϝাāϰা āχāύāĻĢ্āϞুāϝ়েāĻž্āϜা āĻ…āύ্āϝাāύ্āϝ āϜীāĻŦাāĻŖু: āĻ•্āϞ্āϝাāĻŽাāχāĻĄিāϝ়া āϟ্āϰ্āϝাāĻ•োāĻŽাāϟিāϏ

āĻŽাāϤ্āϰা āĻ“ āĻŦ্āϝāĻŦāĻšাāϰ āĻŦিāϧি : āφāĻ•্āϰাāύ্āϤ āϚোāĻ–ে āĻāĻ• āĻĢোঁāϟা āĻ•āϰে āĻĻিāύে ā§Š āĻŦাāϰ āĻĒ্āϰāϝ়োāĻ— āĻ•āϰāϤে āĻšāĻŦে। āϚিāĻ•িā§ŽāϏাāϰ āϏāĻŽāϝ়āĻ•াāϞ: ā§­ āĻĻিāύ।

āϝেāϏāĻŦ āĻ•্āώেāϤ্āϰে āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰা āϝাāĻŦে āύা : āĻŽāĻ•্āϏিāĻĢ্āϞāĻ•্āϏাāϏিāύ, āĻ…āύ্āϝাāύ্āϝ āĻ•ুāχāύোāϞোāύ āĻāĻŦং āĻāχ āĻ“āώুāϧেāϰ āĻ…āύ্āϝাāύ্āϝ āωāĻĒাāĻĻাāύেāϰ āĻĒ্āϰāϤি āϏংāĻŦেāĻĻāύāĻļীāϞ āϰোāĻ—ীāĻĻেāϰ āĻ•্āώেāϤ্āϰে āĻāχ āĻ“āώুāϧ āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰা āϝাāĻŦে āύা।


āĻ—āϰ্āĻ­াāĻŦāϏ্āĻĨা āĻ“ āϏ্āϤāύ্āϝāĻĻাāύāĻ•াāϞে āĻŦ্āϝāĻŦāĻšাāϰ : āϝেāĻšেāϤু āĻāχ āĻ“āώুāϧ āĻ—āϰ্āĻ­াāĻŦāϏ্āĻĨাāϝ় āĻŦ্āϝāĻŦāĻšাāϰেāϰ āĻ•্āώেāϤ্āϰে āĻĒāϰ্āϝাāĻĒ্āϤ āϤāĻĨ্āϝ āĻĒাāĻ“āϝ়া āϝাāϝ়āύি āϤাāχ āĻ­্āϰুāĻŖেāϰ āĻুঁāĻ•ি āĻ“ āϰোāĻ—ীāϰ āωāĻĒāĻ•াāϰেāϰ āĻ•āĻĨা āĻŦিāĻŦেāϚāύা āĻ•āϰে āĻāχ āĻ“āώুāϧ āĻĒ্āϰāϝ়োāĻ— āĻ•āϰা āωāϚিāϤ। āĻŽাāύুāώেāϰ āĻĻুāϧে āĻŽāĻ•্āϏিāĻĢ্āϞāĻ•্āϏাāϏিāύ āύিঃāϏৃāϤ āĻšāϝ় āĻ•িāύা āϤা āĻĒāϰীāĻ•্āώা āĻ•āϰে āĻĻেāĻ–া āĻšāϝ়āύি।
āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ•্āϰিāϝ়া : āϏāϚāϰাāϚāϰ āĻĻেāĻ–া āϝাāϝ় āĻāĻŽāύ āϚোāĻ–েāϰ āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ•্āϰিāϝ়াāĻ—ুāϞোāϰ āĻŽāϧ্āϝে āϰāϝ়েāĻ›ে āĻ•āύāϜাংāϟিāĻ­াāϰ āĻĒ্āϰāĻĻাāĻš, āĻĻৃāώ্āϟিāϰ āϤীāĻ•্āώ্āĻŽāϤা āĻš্āϰাāϏ, āϚোāĻ–েāϰ āĻļুāώ্āĻ•āϤা, āĻ•āϰ্āĻŖিāϝ়াāϰ āĻĒ্āϰāĻĻাāĻš, āϚোāĻ–ে āĻ…āĻļ্āĻŦāϏ্āϤিāĻ­াāĻŦ, āĻšাāχāĻĒাāϰেāĻŽিāϝ়া, āĻŦ্āϝāĻĨা, āϚুāϞāĻ•াāύি, āϏাāĻŦāĻ•āύāϜাংāϟিāĻ­াāϰ āϰāĻ•্āϤāĻ•্āώāϰāĻŖ āĻāĻŦং āϚোāĻ– āĻĻিāϝ়ে āĻĒাāύি āĻĒāĻĄ়া। āĻāϏāĻŦ āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ•্āϰিāϝ়াāĻ—ুāϞো ā§§ āĻĨেāĻ•ে ā§Ŧ% āϰোāĻ—ীāϰ āĻ•্āώেāϤ্āϰে āĻĻেāĻ–া āϝাāϝ়। āĻ…āύ্āϝাāύ্āϝ āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ•্āϰিāϝ়াāĻ—ুāϞো āĻšāϞ āϜ্āĻŦāϰ, āĻ•াāĻļি āĻŦৃāĻĻ্āϧি āĻĒাāĻ“āϝ়া, āĻŽāϧ্āϝāĻ•āϰ্āĻŖে āĻĒ্āϰāĻĻাāĻš, āϜীāĻŦাāĻŖু āĻĻ্āĻŦাāϰা āϏৃāώ্āϟ āϰোāĻ—েāϰ āϏংāĻ•্āϰāĻŽāĻŖ, āĻĢ্āϝাāϰিংāϏ্‌ āĻāϰ āĻĒ্āϰāĻĻাāĻš, āϰ‌্āϝাāĻļ āĻāĻŦং āϰাāχāύাāχāϟিāϏ। āĻāϏāĻŦ āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ•্āϰিāϝ়াāĻ—ুāϞো ā§§-ā§Ē% āϰোāĻ—ীāϰ āĻ•্āώেāϤ্āϰে āĻĻেāĻ–া āϝাāϝ়।


Post a Comment

Previous Post Next Post

POST ADS1

POST ADS 2